Price Chart
Key Statistics
Previous Close
$21.35Day Range
N/A52-Week Range
Avg Volume
259Dividend Yield
—Expense Ratio
0.55%AUM
$1.6MShares Outstanding
49.5KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Country Allocation
| Country | Weight % |
|---|---|
| United States | 78.23% |
| Other | 20.47% |
| Ireland | 1.30% |
Fund Information
- Issuer
- Milliman
- Inception Date
- Apr 21, 2026
- Description
- MHIP aims to preserve and enhancepurchasingpower amid rising medical costs through proprietary actuarial data and quantitative modeling. The fundanalysis relies on Mis extensive dataset of real healthcare claims, covering approximately 35 million insured individuals, to project healthcare inflation based on trends in medical and pharmacy costs.Investments consist ofequities and fixed income securities across the healthcare supply chain, along with inflation-hedging instruments such as commodities, TIPS, andTreasury bonds.Typically, MHIP isrebalanced monthly using a quantitative model toreflect changes in US healthcare cost inflation. The strategy increases exposure to equities and commodities during periods of higher inflation and shifts towarddebtwhen inflation is lower.Holdings may also include derivatives such as swaps, options, and futures, as well as ETFs.
The Milliman Healthcare Inflation Plus ETF (MHIP) is an exchange-traded fund issued by Milliman that launched on Apr 21, 2026. It currently manages $1.6M in assets under management. The fund charges an expense ratio of 0.55%. The fund holds 90 securities in its portfolio.
Top 10 holdings represent 66.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | United States Treasury Bill 11/19/2026 | 19.01% | 305,300 | $304K |
| 2 | LLY | Eli Lilly & Co | 12.00% | 147 | $192K |
| 3 | SPYM | State Street SPDR Portfolio S&P 500 ETF | 11.83% | 2,106 | $189K |
| 4 | JNJ | Johnson & Johnson | 4.96% | 297 | $79K |
| 5 | ABBV | AbbVie Inc | 4.56% | 256 | $73K |
| 6 | XFIV | BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | 3.38% | 1,142 | $54K |
| 7 | XHLF | BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | 3.05% | 973 | $49K |
| 8 | TMO | Thermo Fisher Scientific Inc | 2.92% | 69 | $47K |
| 9 | GILD | Gilead Sciences Inc | 2.50% | 255 | $40K |
| 10 | AMGN | Amgen Inc | 2.15% | 77 | $34K |
| 11 | DHR | Danaher Corp | 1.94% | 135 | $31K |
| 12 | UNH | UnitedHealth Group Inc | 1.65% | 62 | $26K |
| 13 | ABT | Abbott Laboratories | 1.64% | 256 | $26K |
| 14 | ISRG | Intuitive Surgical Inc | 1.52% | 55 | $24K |
| 15 | PFE | Pfizer Inc | 1.46% | 767 | $23K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | +0.60% | |
| 1M | +2.03% | |
| 3M | +4.56% | |
| 6M | +7.79% | |
| YTD | +7.17% | |
| 1Y | +7.17% | |
| 3Y | +7.17% | |
| 5Y | +7.17% |
Moving Averages
$20.91
Above 20-Day MA$20.97
Above 50-Day MA$20.36
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$22.57
Current Price
$21.21
52-Week Low
$19.45
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with MHIP:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.